Search
Zinc protoporphyrin
go.drugbank.com/drugs/DB03934ExperimentalSynonyms: Protoporphyrin IX containing Zn, Zinc-protoporphyrin IXCategories: Heterocyclic Compounds with 4 or More RingsLY-2624803
go.drugbank.com/drugs/DB15092InvestigationalLY-2624803 is under investigation in clinical trial NCT01236105 (Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject).
Nalfurafine
go.drugbank.com/drugs/DB13471InvestigationalCategories: Heterocyclic Compounds with 4 or More RingsChelerythrine
go.drugbank.com/drugs/DB17024ExperimentalA benzophenanthridine alkaloid evaluated as a kinase-inhibitor.
Categories: Heterocyclic Compounds with 4 or More RingsNesolicaftor
go.drugbank.com/drugs/DB15239InvestigationalNesolicaftor (PTI-428) is under investigation in clinical trial NCT03258424 (Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background
Synonyms: N-(trans-3-(5-((R)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamidePenequinine, Penehyclidine
go.drugbank.com/drugs/DB16287InvestigationalPenequinine, Penehyclidine is under investigation in clinical trial NCT02644876 (Preventive Effects of Penehyclidine Hydrochloride Inhalation on Postoperative Pulmonary Complications).
Butaperazine
go.drugbank.com/drugs/DB13213ApprovedButaperazine was approved in 1967 [L5143], and possibly discontinued in the 1980s [T397].
Redaporfin
go.drugbank.com/drugs/DB17219InvestigationalSynonyms: 3,3',3'',3'''-(7,8,17,18-tetrahydroporphyrin-5,10,15,20-tetrayl)tetrakis(2,4-difluoro-n-methylbenzenesulfonamide), Benzenesulfonamide, 3,3',3'',3'''-(7,8,17,18-tetrahydro-21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(2,4-difluoro-n-methyl-Categories: Heterocyclic Compounds with 4 or More RingsOridonin
go.drugbank.com/drugs/DB19086InvestigationalOridonin is under investigation in clinical trial NCT05130892 (Effect of Inflammasome Inhibitor on Hscrp in Patients After PCI).
Synonyms: Kaur-16-en-15-one, 7.alpha.,20-epoxy-1.alpha.,6.beta.,7,14-tetrahydroxy-, (14r)-, Kaur-16-en-15-one, 7,20-epoxy-1,6,7,14-tetrahydroxy-, (1.alpha.,6.beta.,7.alpha.,14r)-OSU-6162
go.drugbank.com/drugs/DB19178InvestigationalOSU-6162 is under investigation in clinical trial NCT05641623 (OSU6162 as Add-on in Ssri/snri-resistant Depression).